ACSL4 and metabolic dysfunction-associated steatotic liver disease: Furthermore, the hypomethylation at Acyl-CoA synthetase long-chain family member 4 ACSL4 (cg15536552) is suggested to be a potential biomarker for NAFLD progression [193].